Tag: INFY

4-Pack of Options Ideas & More

Trillium Therapeutics, Inc. TRIL – Recap

Our stock calls continue to produce ample opportunity for big gains, with TRIL being the latest in recent ideas to make a serious mark.

We tagged TRIL in our extended watchlist on Tuesday morning, and that day it registered a low of 1.08. Yesterday, the stock shot to a fantastic new high of 3.43. That works out to profits of up to 218% for any of our readers who caught Tuesday’s alert.

We have been killing it on both the stocks and options fronts here in 2020 so far. We expect that trend to continue indefinitely, and hope you’ll stick with us to see it all play out!

Fresh Options Ideas
INFY 01/17 $10-12.50 Calls
SNX 01/17 $135-145 Calls
KSS 04/17 $50-52.50 Calls
SPY Weekly $326.50-327 Calls*

*Never attempt to trade options with a weekly expiration on a Friday unless you are an advanced level trader with access to disposable funds. 

4-Pack of Options Ideas & More

Trillium Therapeutics, Inc. TRIL – Recap

Our stock calls continue to produce ample opportunity for big gains, with TRIL being the latest in recent ideas to make a serious mark.

We tagged TRIL in our extended watchlist on Tuesday morning, and that day it registered a low of 1.08. Yesterday, the stock shot to a fantastic new high of 3.43. That works out to profits of up to 218% for any of our readers who caught Tuesday’s alert.

We have been killing it on both the stocks and options fronts here in 2020 so far. We expect that trend to continue indefinitely, and hope you’ll stick with us to see it all play out!

Fresh Options Ideas
INFY 01/17 $10-12.50 Calls
SNX 01/17 $135-145 Calls
KSS 04/17 $50-52.50 Calls
SPY Weekly $326.50-327 Calls*

*Never attempt to trade options with a weekly expiration on a Friday unless you are an advanced level trader with access to disposable funds. 

Blue Horseshoe Stocks: Weekly Wrap-Up

Pharma Options Recap

We cast a wide net yesterday with a trio of options ideas in the pharma space related to the reversal of the Trump administration’s position on drug rebate policy. The sector was bustling with activity in the premarket, and two out of our three ideas bore fruit.

Here were the total possible gains available to daytraders for the session:

Cigna Corp. CI $167.50-175 Calls 

$167.50 Calls – Range: 10.04-17.00 – Max Gain: 52%
$170 Calls – Range: 10.02-14.30 – Max Gain: 58%
$175 Calls – Range: 1.10-1.80 – Max Gain: 64%
____

United Health Corp. UNH $250-255 Calls 

$250 Calls – Range: 2.48-11.09 – Max Gain: 52%
$252.50 Calls – Range: 2.50-8.70 – Max Gain: 58%
$255 Calls – Range: .99-6.20 – Max Gain: 70%

In addition to these plays, we’ll continue to keep an eye on the CVS Health Corp. CVS Weekly $57-58.50 Calls  through the end of the day.
____

Fresh Idea:
SPDR S&P500 (ETF) SPY $299-300 Calls

Taronis Technologies, Inc. TRNX

On Monday morning, we highlighted TRNX as a prime bottom-bounce candidate, and we’d like to wrap up the week by going over the solid swings which we subsequently observed in the stock.

On Monday itself, our choice in timing on calling this play was affirmed as we saw a solid 52% run from  .25-.38. This was followed by a pullback to a low of .1832 the following day, and over the course of the rest of the week, TRNX has stair-stepped its way back up to .34, which represents an additional 86% swing.

Extended Watchlist:
MLNT, CLVS, NVCN, APLS, SFIX, ADXS, INFY, OBLN